09:34 EDT Mirati Therapeutics trading halted, volatility trading pause
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on MRTX:
- Mirati Therapeutics price target lowered to $31 from $40 at BMO Capital
- Mirati Therapeutics price target raised to $83 from $77 at Stifel
- Mirati Therapeutics assumed with an Overweight at Piper Sandler
- Mirati Therapeutics upgraded to Buy from Neutral at B. Riley
- Mirati Therapeutics 9.7M share Spot Secondary priced at $27.80